Alvarez, J M <br/><br/>
Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Sep 2001 
 - 457-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1067/mtc.2001.115701  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aprotinin--therapeutic use<br/>Aspirin--adverse effects<br/>Blood Component Transfusion--statistics & numerical data<br/>Combined Modality Therapy<br/>Coronary Artery Bypass--adverse effects<br/>Coronary Disease--drug therapy<br/>Double-Blind Method<br/>Drainage<br/>Female<br/>Hemoglobins--analysis<br/>Hemostatics--therapeutic use<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Mediastinum<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Postoperative Care--methods<br/>Postoperative Hemorrhage--blood<br/>Prospective Studies<br/>Time Factors